Collaboration Station

Where CMI, Compas, Singularity, InfoCures, & MEDtrak Come Together!

The Scoop-Right to Try| The Ear| Consumers are Good January 12, 2015

Filed under: Corporate — CMI/Compas @ 5:09 pm

NY Times reports this story on the ‘Right to Try’ laws which allow critically ill patients the opportunity to try drugs not yet approved by the FDA. Unsurprisingly, the introduction of ‘Right to Try’ has sparked debate as critics say experimenting with unapproved drugs could cause more harm than good. Still, many patients with life-ending diagnoses want the option.

Startup Otonomy  is among others including Pfizer, Novartis, and Roche who have heard and responded to the need for better treatment of ear conditions.

Groundbreaking new technology—an implant that attaches to the spine—may help paralyzed people walk again.

These are 10 affordable and cool products showcased at CES…I love #7.

Consumers are good. Mashable reports that Americans expect companies to incorporate social good and community service into their business models, and a staggering 90% say they are more likely to trust and stay loyal to a brand that tries to make a difference.

-Amanda Kopec Preto, Manager, Strategic Marketing & Corporate Communications


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s